Member Info for MIKODX

Rud20 - Spot on. Only the company and the big investors will benefit, shareholders will get shafted as always. Better off investing elsewhere, much better stocks out there to be fooling around with this very small cap company.

Helium One is a totally different company. They are in the business of producing Helium, a highly sort after commodity. Any good news they get, the SP generally takes off. However, because of the constant dilution, it doesn't move as fast as it once did. Genedrive on the other hand are not selling a product as highly sort after as Helium, and they also have a couple of competitors in that market. You cannot compare the two companies, they are both very different.

Lol funniest thing I've heard all day. The bottom will be less than a fraction of a penny. Then it will drop into oblivion, you've been warned.

Anyone listening to this claptrap needs their heads tested. Investing more here is a massive risk, you could lose the lot.

So by the end of this fundraise the company will have over 2B shares in circulation. Absolutely diabolical. Might as well take your shares and flush it down the toilet. They are attempting to take the company down so that they can go private, it’s pretty obvious now. This is the beginning of the end.

It is expected that settlement of the 9,253,679 First Tranche Placing Shares will take place on or around 26 September 2025 and First Admission will become effective and dealings in the First Tranche Placing Shares will commence at that time. It is expected that settlement of the 45,487,903 Second Tranche Placing Shares (which includes the 5,473,684 Subscription Shares) will take place within one trading day of First Admission, on or around 29 September 2025, and that the Second Admission will become effective and dealings in the Second Tranche Placing Shares will commence at that time.

Following First and Second Admission, the Company will have 385,947,594 Ordinary Shares in issue.

Good move by the board to do the Placing at this time. 10p was always going to be top price at this current time. Getting in when they did has guaranteed maximum gains without massive dilution. 386M at this point of the companys journey isn't bad at all. With Tempus onboard and projected turnover, this should start flying by next year.

Looks like we might see a doubling of last year’s revenue, but debt and cashburn is still high. We might get a few spikes here and there, but until we get an announcement stating that they will be working on cutting costs and reducing cashburn, I think this will stay under ten. This is just my opinion of course, DYOR.

Hasn't this been announced yet?

I agree this will go up but it wont be anytime soon. I'm expecting maybe in a year or two. But this stock is very sensitive to sentiment and the dilution wasn't too bad so you never know, it could still rise before the end of the year. Fingers crossed.

Especially when used with capital. Jog on.

BusinessOwner it's not nonsense it's facts and I called it right. Just because your predictions are lousy, stop being jealous lol.

I know it's an old thread, but if you read through it you will find out exactly who the rampers are, and the ones who dont have a clue what they're talking about. I've been saying all along a Fundraise was coming, and here it is.

Good to see this rising above ten, thought it was going to stay under.

Renalytix is funded and projected to deliver anticipated profitability in two years with no further funding requirements.

Really? Where is that quoted? Well the market doesn’t think so and going by latest developments it’s plain to see that the money raised from the last fundraise is fast running out. They will most definitely be seeking further funding in the coming months. Very ingenious of you to be stating otherwise.

Let’s get this into perspective. Without doubt exciting times for the company. However, shareholders will not benefit if the company doesn’t improve on their monthly cashburn. Currently eating through almost 1.5M per month. Shareholders will suffer losses instead of gains if things dont improve from a financial aspect. So yes this should be flying after the latest deal but it is being suppressed due to the market being fully aware of their financial position.

Futurehire - The reason Hemo is flying is because they recently consolidated their shares, hence the volatility. No such thing has happened over here so I think your clutching at straws . I was going to jump into Hemo a few weeks back but the wild swings put me off. Wish I did now.

The ramping on here is nothing short of diabolical. I've no doubt Renalytix are and will continue doing well with their products. But that doesn't mean the PI will do well, especially considering the financial turmoil the company is currently in. Wont be long before there is another fundraise, so I dont know what makes people think this is going to rocket up from here. Sorry to burst your bubble, but it wont. Not until there is more clarity on where the company is financially. So please you rampers, put a sock in it fgs.

Rocket79 - I disagree. The reason this has dropped is because this has actually re-rated. The news on Monday had a positive impact on the SP which caused it to spike. Unfortunately judging by the comments it seems quite a few people got spiked. The market is still aware that the company is still operating at a a loss and still carry heavy debts, hence the pullback This won’t be going back up anytime soon unless we get a positive RNS about the company’s finances.

We need more good news like we received on Monday. The market still thinks the company is in financial trouble which is why it's dropped back down. Good opportunity to buy in, not so good if the company still haven't sorted the finances.

UBS has been pumping and dumping this stock multiple times this year, surprised no one has picked up on it. For this to continue on it's so far short-lived upward climb, we need some good news. I think this wll come as we approach the end of year results. The company has done very well so far this year with increased contracts and sales. The climb could just be starting, with some good news this could really start to climb. We all know this stock moves very quickly due to the solid fundamentals of the company.